Codan Limited - CDA.AX

CDA.AX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CDA.AX	-1.2	3.5	-0.2	3.6	26.2	101.1	79.0	113.3	1881.6	1368.2
S&P 500	-0.5	-1.3	2.2	3.9	11.1	22.6	33.7	83.9	202.7	34097.7

Compare CDA.AX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CDA.AX
name	Codan Limited
price	16.15
changes percentage	-1.1628
change	-0.19
day low	16.04
day high	16.51
year high	16.81
year low	7.91
market cap	2932113250
price avg 50	15.9514
price avg 200	13.92445
exchange	ASX
volume	176738
avg volume	263252
open	16.39
previous close	16.34
eps	0.45
pe	35.89
earnings announcement	2025-02-21T10:59:00.000+0000
shares outstanding	181555000
timestamp	2025-01-30 05:10:50

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 70.3%

Overall Quarterly Financial Health: 73.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	550459000	456468000	20.59
gross profit	305225000	218587000	39.64
gross profit ratio	0.55	0.48	15.79
research and development expenses	54522000	46547000	17.13
operating expenses	209324000	126819000	65.06
interest income	0	50000	-100.00
interest expense	9437000	5376000	75.54
ebitda	147099000	120635000	21.94
ebitdaratio	0.27	0.26	1.12
operating income	95901000	91768000	4.50
operating income ratio	0.17	0.2	-13.34
net income	81387000	67774000	20.09
net income ratio	0.15	0.15	-0.42
eps	0.45	0.37	21.62

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 550 million in 2024 from 456 million in 2023 representing a change of 20.59%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 305 million in 2024 from 219 million in 2023 representing a change of 39.64%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 55 million in 2024 from 47 million in 2023 representing a change of 17.13%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 147 million in 2024 from 121 million in 2023 representing a change of 21.94%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 96 million in 2024 from 92 million in 2023 representing a change of 4.5%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 81 million in 2024 from 68 million in 2023 representing a change of 20.09%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.45 in 2024 from 0.45 in 2023 representing a change of 21.62%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 209 million in 2024 from 127 million in 2023 representing a change of 65.06%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
revenue	284541000	265918000	7.00
gross profit	159120000	128026000	24.29
gross profit ratio	0.56	0.48	16.15
research and development expenses	36443000	18079000	101.58
operating expenses	81157000	73645000	10.20
interest income	0	90000	-100.00
interest expense	4849000	4675000	3.72
ebitda	64853500	57655500	12.48
ebitdaratio	0.23	0.22	5.12
operating income	60060000	54381000	10.44
operating income ratio	0.21	0.2	3.21
net income	43348000	38039000	13.96
net income ratio	0.15	0.14	6.50
eps	0.24	0.21	14.29

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 285 million in 2024Q4 from 266 million in 2024Q2 representing a change of 7.0%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 159 million in 2024Q4 from 128 million in 2024Q2 representing a change of 24.29%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 36 million in 2024Q4 from 18 million in 2024Q2 representing a change of 101.58%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 65 million in 2024Q4 from 58 million in 2024Q2 representing a change of 12.48%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 60 million in 2024Q4 from 54 million in 2024Q2 representing a change of 10.44%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 43 million in 2024Q4 from 38 million in 2024Q2 representing a change of 13.96%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.24 in 2024Q4 from 0.24 in 2024Q2 representing a change of 14.29%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 81 million in 2024Q4 from 74 million in 2024Q2 representing a change of 10.2%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	768711000	693301000	10.88
total liabilities	321779000	286966000	12.13
total equity	446932000	406335000	9.99
cash and cash equivalents	19703000	23661000	-16.73
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	258906000	234291000	10.51
total non current assets	509805000	459010000	11.07
total current liabilities	155401000	138361000	12.32
total non current liabilities	166378000	148605000	11.96
common stock	50319000	49196000	2.28
retained earnings	304204000	259079999	17.42
total debt	141046000	125391000	12.48

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 769 million in 2024 from 693 million in 2023 representing a change of 10.88%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 447 million in 2024 from 406 million in 2023 representing a change of 9.99%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 259 million in 2024 from 234 million in 2023 representing a change of 10.51%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 50 in 2024 from 49 in 2023 representing a change of 2.28%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 304 million in 2024 from 259 million in 2023 representing a change of 17.42%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 322 million in 2024 from 287 million in 2023 representing a change of 12.13%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 20 million in 2024 from 24 million in 2023 representing a change of -16.73%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 155 million in 2024 from 138 million in 2023 representing a change of 12.32%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 141 million in 2024 from 125 million in 2023 representing a change of 12.48%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
total assets	768711000	740424000	3.82
total liabilities	321779000	322726000	-0.29
total equity	446932000	417698000	7.00
cash and cash equivalents	19703000	23593000	-16.49
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	258906000	245397000	5.50
total non current assets	509805000	495027000	2.99
total current liabilities	155401000	135688000	14.53
total non current liabilities	166378000	187038000	-11.05
common stock	50319000	50319000	0.00
retained earnings	304204000	279894000	8.69
total debt	141046000	154371000	-8.63

Overall Score of Quarterly Balance Sheet

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 769 million in 2024Q4 from 740 million in 2024Q2 representing a change of 3.82%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 322 million in 2024Q4 from 323 million in 2024Q2 representing a change of -0.29%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 447 million in 2024Q4 from 418 million in 2024Q2 representing a change of 7.0%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 259 million in 2024Q4 from 245 million in 2024Q2 representing a change of 5.5%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 304 million in 2024Q4 from 280 million in 2024Q2 representing a change of 8.69%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 141 million in 2024Q4 from 154 million in 2024Q2 representing a change of -8.63%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 20 million in 2024Q4 from 24 million in 2024Q2 representing a change of -16.49%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 155 million in 2024Q4 from 136 million in 2024Q2 representing a change of 14.53%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	-3958000	1048000	-477.67
operating cash flow	106450000	79877000	33.27
free cash flow	55666000	30513000	82.43
capital expenditure	-50784000	-49364000	-2.88
depreciation and amortization	33086000	28867000	14.62
deferred income tax	0	-75202000	100.00
stock based compensation	0	740000	-100.00
accounts payables	-127000	12488000	-101.02
inventory	15971000	-18913000	184.44
acquisitions net	-37236000	-4561999	-716.22
investments in property plant and equipment	-10122000	-49364000	79.50
net cash used for investing activites	-87962000	-53926000	-63.12
debt repayment	19745000	23380000	-15.55
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-36263000	-43480000	16.60
net cash used provided by financing activities	-22431000	-25455000	11.88
cash at end of period	19703000	23661000	-16.73
accounts receivables	0	-10303000	100.00
cash at beginning of period	23661000	22613000	4.63

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4 million in 2024 from 1 million in 2023 representing a change of -477.67%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -75 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024 from -10 million in 2023 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 106 million in 2024 from 80 million in 2023 representing a change of 33.27%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 56 million in 2024 from 31 million in 2023 representing a change of 82.43%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -51 million in 2024 from -49 million in 2023 representing a change of -2.88%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024 from 1 million in 2023 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 12 million in 2023 representing a change of -101.02%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -36 million in 2024 from -43 million in 2023 representing a change of 16.6%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
operating cash flow	65040000	41410000	57.06
free cash flow	58536000	19344000	202.61
capital expenditure	-6504000	-22066000	70.52
depreciation and amortization	33086000	0	NaN
deferred income tax	0	0	NaN
stock based compensation	335000	467000	-28.27
accounts receivables	-17195000	0	NaN
accounts payables	0	0	NaN
inventory	15971000	0	NaN
acquisitions net	-6926000	-29045000	76.15
investments in property plant and equipment	-6504000	-22066000	70.52
net cash used for investing activites	-36851000	-51111000	27.90
debt repayment	0	30745000	-100.00
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-19038000	-17225000	-10.53
net cash used provided by financing activities	-32522000	10091000	-422.29
net change in cash	-3890000	-68000	-5620.59
cash at end of period	19703000	23593000	-16.49
cash at beginning of period	23593000	23661000	-0.29

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4 million in 2024Q4 from 0 million in 2024Q2 representing a change of -5620.59%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -7 million in 2024Q4 from -22 million in 2024Q2 representing a change of 70.52%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -19 million in 2024Q4 from -17 million in 2024Q2 representing a change of -10.53%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 65 million in 2024Q4 from 41 million in 2024Q2 representing a change of 57.06%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 59 million in 2024Q4 from 19 million in 2024Q2 representing a change of 202.61%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q4 from 0 million in 2024Q2 representing a change of -28.27%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -17 million in 2024Q4 from 0 million in 2024Q2 representing a change of nan%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	3.04	2.52	20.45
net income per share	0.45	0.37	19.94
operating cash flow per share	0.59	0.44	33.11
free cash flow per share	0.31	0.17	82.21
cash per share	0.11	0.13	-16.83
book value per share	2.47	2.25	9.86
tangible book value per share	0.79	-1.32	159.39
shareholders equity per share	2.47	2.25	9.87
interest debt per share	0.83	0.72	14.94
market cap	2138141060.27	1452040761.82	47.25
enterprise value	2259484060.27	1553770761.82	45.42
pe ratio	26.27	21.42	22.62
price to sales ratio	3.88	3.18	22.11
pocfratio	20.09	18.18	10.49
pfcf ratio	38.41	47.59	-19.29
pb ratio	4.78	3.57	33.86
ptb ratio	4.78	3.57	33.86
ev to sales	4.1	3.4	20.59
enterprise value over ebitda	15.36	12.88	19.26
ev to operating cash flow	21.23	19.45	9.12
ev to free cash flow	40.59	50.92	-20.29
earnings yield	0.04	0.05	-18.45
free cash flow yield	0.03	0.02	23.89
debt to equity	0.32	0.31	2.26
debt to assets	0.18	0.18	1.45
net debt to ebitda	0.82	0.84	-2.18
current ratio	1.67	1.69	-1.61
interest coverage	10.16	17.07	-40.47
income quality	1.31	1.18	10.98
dividend yield	0.02	0.03	-43.36
payout ratio	0.45	0.64	-30.55
sales general and administrative to revenue	0.09	0.08	7.48
research and ddevelopement to revenue	0.1	0.1	-2.87
intangibles to total assets	0.4	0.93	-57.46
capex to operating cash flow	0.48	0.62	-22.80
capex to revenue	0.09	0.11	-14.69
capex to depreciation	1.53	1.71	-10.24
stock based compensation to revenue	0	0.0	-100.00
graham number	5.0	4.36	14.80
roic	0.12	0.13	-10.25
return on tangible assets	0.18	1.42	-87.69
graham net net	-0.98	-0.8	-22.12
working capital	103505000	95930000	7.90
tangible asset value	142340000	-239389000	159.46
net current asset value	-62873000	-52675000	-19.36
invested capital	482685000	817916000	-40.99
average receivables	84035500	68704000	22.32
average payables	48236000	44309000	8.86
average inventory	118236000	117061000	1.00
days sales outstanding	62.25	59.32	4.94
days payables outstanding	73.76	71.98	2.47
days of inventory on hand	163.82	193.95	-15.53
receivables turnover	5.86	6.15	-4.71
payables turnover	4.95	5.07	-2.41
inventory turnover	2.23	1.88	18.39
roe	0.18	0.17	9.17
capex per share	0.28	0.27	2.75

• Positive

  ROE: Return on Equity (ROE) increased to 0.18 on 2024-06-30 from 0.17 on 2023-06-30, representing a change of 9.17%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 26.27 on 2024-06-30 from 21.42 on 2023-06-30, representing a change of 22.62%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.67 on 2024-06-30 from 1.69 on 2023-06-30, representing a change of -1.61%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.32 on 2024-06-30 from 0.31 on 2023-06-30, representing a change of 2.26%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q4	2023-12-31 Q2	Q/Q change %
CDA.AX
calendar year	2024	2024	NaN
revenue per share	1.57	1.47	7.00
net income per share	0.24	0.21	13.96
operating cash flow per share	0.36	0.23	57.06
free cash flow per share	0.32	0.11	202.61
cash per share	0.11	0.13	-16.49
book value per share	2.46	2.3	7.00
tangible book value per share	0.79	0.65	21.48
shareholders equity per share	2.47	2.31	7.03
interest debt per share	0.8	0.88	-8.27
market cap	2141343294.53	1550252655.0	38.13
enterprise value	2262686294.53	1681030655.0	34.60
pe ratio	12.35	10.19	21.21
price to sales ratio	7.53	5.83	29.09
pocfratio	32.92	37.44	-12.06
pfcf ratio	36.58	80.14	-54.35
pb ratio	4.79	3.71	29.06
ptb ratio	4.79	3.71	29.06
ev to sales	7.95	6.32	25.79
enterprise value over ebitda	34.89	29.16	19.66
ev to operating cash flow	34.79	40.59	-14.30
ev to free cash flow	38.65	86.9	-55.52
earnings yield	0.02	0.02	-17.50
free cash flow yield	0.03	0.01	119.08
debt to equity	0.32	0.37	-14.63
debt to assets	0.18	0.21	-11.99
net debt to ebitda	1.87	2.27	-17.51
current ratio	1.67	1.81	-7.88
interest coverage	12.39	11.63	6.48
income quality	1.5	1.09	37.83
dividend yield	0.01	0.01	-19.98
payout ratio	0.44	0.45	-3.01
sales general and administrative to revenue	0.09	0.09	3.37
research and ddevelopement to revenue	0.13	0.07	88.38
intangibles to total assets	0.4	0.41	-2.38
capex to operating cash flow	0.1	0.53	-81.23
capex to revenue	0.02	0.08	-72.45
capex to depreciation	0.2	0	NaN
stock based compensation to revenue	0.0	0.0	-32.96
graham number	3.64	3.3	10.44
roic	0.08	0.07	12.63
return on tangible assets	0.09	0.09	8.01
graham net net	-0.97	-1.01	3.89
working capital	103505000	109709000	-5.65
tangible asset value	142340000	117172000	21.48
net current asset value	-62873000	-77329000	18.69
invested capital	482685000	486250000	-0.73
average receivables	84370000	74522500	13.21
average payables	79115500	77792500	1.70
average inventory	114240000	122407000	-6.67
days sales outstanding	29.7	25.34	17.21
days payables outstanding	35.56	70.93	-49.86
days of inventory on hand	78.98	77.29	2.20
receivables turnover	3.03	3.55	-14.68
payables turnover	2.53	1.27	99.45
inventory turnover	1.14	1.16	-2.15
roe	0.1	0.09	6.47
capex per share	0.04	0.12	-70.52

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.35 on 2024-06-30 Q4 from 10.19 on 2023-12-31 Q2, representing a change of 21.21%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.32 on 2024-06-30 Q4 from 0.37 on 2023-12-31 Q2, representing a change of -14.63%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.67 on 2024-06-30 Q4 from 1.81 on 2023-12-31 Q2, representing a change of -7.88%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 9.87 which is lower than current price 16.15, indicates the company may be overvalued.